Cargando…

Analysis of risk factors for perioperative death in patients undergoing aortic valve replacement using biological valves

BACKGROUND: Aortic valve disease has become one of the important factors affecting human health. Aortic valve disease is a progressive disease, if not actively treated, the prognosis is poor. Aortic valve replacement (AVR) surgery is an important treatment for aortic valve disease. At present, the A...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qi, Gao, Hongbo, Ji, Qiuxia, Song, Jianshu, Li, Longfei, Liu, Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769375/
https://www.ncbi.nlm.nih.gov/pubmed/33350790
http://dx.doi.org/10.1097/MD.0000000000023909
_version_ 1783629311101632512
author Li, Qi
Gao, Hongbo
Ji, Qiuxia
Song, Jianshu
Li, Longfei
Liu, Xu
author_facet Li, Qi
Gao, Hongbo
Ji, Qiuxia
Song, Jianshu
Li, Longfei
Liu, Xu
author_sort Li, Qi
collection PubMed
description BACKGROUND: Aortic valve disease has become one of the important factors affecting human health. Aortic valve disease is a progressive disease, if not actively treated, the prognosis is poor. Aortic valve replacement (AVR) surgery is an important treatment for aortic valve disease. At present, the AVR surgery using biological valve accounts for about 40% of the total number of AVR surgery. There are still more perioperative deaths in China due to the large number of AVR patients using biological valves. The objective of this study is to explore measures to reduce perioperative mortality of patients after AVR surgery with biological valves. METHODS: The clinical data of patients undergoing AVR surgery with biological valves in Affiliated Hospital of Qingdao University from November 15, 2020 to December 31, 2022 were reviewed and analyzed. Patients were divided into death group and survival group according to their perioperative survival. Risk factors that may influence perioperative mortality were analyzed and compared between the 2 groups. DISCUSSION: This study was a retrospective analysis of risk factors that may influence perioperative mortality in patients undergoing AVR surgery using biological valves. The conclusions of this study can be used to guide clinical decisions-making and relevant guidelines-developing for perioperative treatment of patients undergoing AVR surgery using biological valves.
format Online
Article
Text
id pubmed-7769375
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-77693752020-12-29 Analysis of risk factors for perioperative death in patients undergoing aortic valve replacement using biological valves Li, Qi Gao, Hongbo Ji, Qiuxia Song, Jianshu Li, Longfei Liu, Xu Medicine (Baltimore) 3400 BACKGROUND: Aortic valve disease has become one of the important factors affecting human health. Aortic valve disease is a progressive disease, if not actively treated, the prognosis is poor. Aortic valve replacement (AVR) surgery is an important treatment for aortic valve disease. At present, the AVR surgery using biological valve accounts for about 40% of the total number of AVR surgery. There are still more perioperative deaths in China due to the large number of AVR patients using biological valves. The objective of this study is to explore measures to reduce perioperative mortality of patients after AVR surgery with biological valves. METHODS: The clinical data of patients undergoing AVR surgery with biological valves in Affiliated Hospital of Qingdao University from November 15, 2020 to December 31, 2022 were reviewed and analyzed. Patients were divided into death group and survival group according to their perioperative survival. Risk factors that may influence perioperative mortality were analyzed and compared between the 2 groups. DISCUSSION: This study was a retrospective analysis of risk factors that may influence perioperative mortality in patients undergoing AVR surgery using biological valves. The conclusions of this study can be used to guide clinical decisions-making and relevant guidelines-developing for perioperative treatment of patients undergoing AVR surgery using biological valves. Lippincott Williams & Wilkins 2020-12-24 /pmc/articles/PMC7769375/ /pubmed/33350790 http://dx.doi.org/10.1097/MD.0000000000023909 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 3400
Li, Qi
Gao, Hongbo
Ji, Qiuxia
Song, Jianshu
Li, Longfei
Liu, Xu
Analysis of risk factors for perioperative death in patients undergoing aortic valve replacement using biological valves
title Analysis of risk factors for perioperative death in patients undergoing aortic valve replacement using biological valves
title_full Analysis of risk factors for perioperative death in patients undergoing aortic valve replacement using biological valves
title_fullStr Analysis of risk factors for perioperative death in patients undergoing aortic valve replacement using biological valves
title_full_unstemmed Analysis of risk factors for perioperative death in patients undergoing aortic valve replacement using biological valves
title_short Analysis of risk factors for perioperative death in patients undergoing aortic valve replacement using biological valves
title_sort analysis of risk factors for perioperative death in patients undergoing aortic valve replacement using biological valves
topic 3400
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769375/
https://www.ncbi.nlm.nih.gov/pubmed/33350790
http://dx.doi.org/10.1097/MD.0000000000023909
work_keys_str_mv AT liqi analysisofriskfactorsforperioperativedeathinpatientsundergoingaorticvalvereplacementusingbiologicalvalves
AT gaohongbo analysisofriskfactorsforperioperativedeathinpatientsundergoingaorticvalvereplacementusingbiologicalvalves
AT jiqiuxia analysisofriskfactorsforperioperativedeathinpatientsundergoingaorticvalvereplacementusingbiologicalvalves
AT songjianshu analysisofriskfactorsforperioperativedeathinpatientsundergoingaorticvalvereplacementusingbiologicalvalves
AT lilongfei analysisofriskfactorsforperioperativedeathinpatientsundergoingaorticvalvereplacementusingbiologicalvalves
AT liuxu analysisofriskfactorsforperioperativedeathinpatientsundergoingaorticvalvereplacementusingbiologicalvalves